Biggest News Aggregation in the World
📰 Aptose Bioscience News

Page 2 - Aptose Bioscience News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Aptose Bioscience. Real-time updates on events, politics, business and more.

Oppenheimer Equities Analysts Raise Earnings Estimates for Aptose Biosciences Inc. (NASDAQ:APTO)

Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Investment analysts at Oppenheimer upped their FY2025 EPS estimates for Aptose Biosciences in a note issued to investors on Tuesday, August 2nd. Oppenheimer analyst M. Biegler now expects that the biotechnology company will earn $0.33 per share for the year, up from their prior forecast of […]
United States Aptose Bioscience Aptose Biosciences Sequoia Financial Advisors Texas Capital Bank Wealth Management Services Inc Toronto Dominion Bank

Critical Contrast: Aptose Biosciences (NASDAQ:APTO) & Caribou Biosciences (NASDAQ:CRBU)

Aptose Biosciences (NASDAQ:APTO – Get Rating) and Caribou Biosciences (NASDAQ:CRBU – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings. Institutional and Insider Ownership 34.2% of Aptose Biosciences shares […]
United States Aptose Bioscience Aptose Biosciences Caribou Biosciences Inc Crystalgenomics Inc Aptose Biosciences Inc

Analysts Offer Predictions for Aptose Biosciences Inc.'s Q1 2023 Earnings (NASDAQ:APTO)

Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Investment analysts at Piper Sandler issued their Q1 2023 earnings estimates for shares of Aptose Biosciences in a report released on Tuesday, March 22nd. Piper Sandler analyst E. Tenthoff anticipates that the biotechnology company will earn ($0.16) per share for the quarter. Piper Sandler also issued […]
Aptose Bioscience Aptose Biosciences Piper Sandler Morgan Stanley Zacks Investment Research Alliance Global Partners

Aptose Biosciences Inc. Forecasted to Earn Q1 2022 Earnings of ($0.13) Per Share (NASDAQ:APTO)

Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Stock analysts at Oppenheimer issued their Q1 2022 earnings estimates for shares of Aptose Biosciences in a research note issued to investors on Wednesday, March 23rd. Oppenheimer analyst M. Biegler expects that the biotechnology company will post earnings per share of ($0.13) for the quarter. Oppenheimer […]
Aptose Bioscience Aptose Biosciences Virtu Financial Zacks Investment Research Alliance Global Partners Aptose Biosciences Inc

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science